Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its.
Arbutus Completes Enrollment in its Phase 2a Clinical Trial Combining AB-729 with NA Therapy and Peginterferon alfa-2a in Patients with Chronic Hepatitis B Virus Infection streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Arbutus to Present at Chardan s 6th Annual Genetic Medicines Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.